Loss of communication in ovarian cancer

American Journal of Obstetrics and Gynecology

Volumn 194, Issue 5, 2006, Pages

  Toler, Chris R ^a   Taylor, Douglas D ^a   Gercel Taylor, Cicek ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Connexin; Drug sensitivity; Ovarian cancer

Indexed keywords

CARBOPLATIN; CONNEXIN 26; CONNEXIN 43; PACLITAXEL;

ARTICLE; CANCER CELL; CHEMOSENSITIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY TEST; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; CARBOPLATIN; CELL LINE, TUMOR; CONNEXIN 43; CONNEXINS; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; PACLITAXEL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33646097446     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.01.024     Document Type: Article

References (12)

1. Sawey M. Role of gap junctional communication in breast cancer progression and chemoprevention. J Nutr 131 (2001) 167S-169S
2. Chipman J., Mally A., and Edwards G. Disruptions of gap junctions in toxicity and carcinogenicity. Toxicol Sci 71 (2003) 146-153
3. Moorby C., and Patel M. Dual functions for connexins: Cx43 regulates cell growth independently of gap junction formation. Exp Cell Res 271 (2001) 238-248
4. Mehta P.P., Bertran J.S., and Lowenstein W.R. Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell 44 (1986) 187-196
5. Lee S.W., Tomasetto C., and Sager R. Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc Nat Acad Sci U S A 88 (1991) 2825-2829
6. Wilgenbus K.K., Kirkpatrick C.J., Knuechel R., Willecke K., and Traub O. Expression of Cx26, Cx32, and Cx43 gap junction proteins in normal and neoplastic human tissues. Int J Cancer 51 (1992) 522-529
7. Chen S.C., Pelletier D.B., Ao P., and Boynton A.L. Connexin43 reverses the phenotype of transformed cells and alters their expression of cyclin/cyclin dependent kinases. Cell Growth Differ 6 (1995) 681-690
8. Fernstrom M.J., Koffler L.D., Abou-Rjaily G., Boucher P.D., Shewach D.S., and Ruch R.J. Neoplastic reversal of human ovarian carcinoma cells transfected with connexin43. Exp Mol Pathol 73 (2002) 54-60
9. Hanna E.A., Umhauer S., Roshong S.L., Piechocki M.P., Fernstrom M.J., Fanning J.D., et al. Gap junctional intercellular communication and connexin43 expression in human ovarian surface epithelial cells and ovarian carcinomas in vivo and in vitro. Carcinogenesis 20 (1999) 1369-1373
10. Spinella F., Rosano L., Di Castro V., Nicotra M.R., Natali P.G., and Bagnato A. Endothelin-1 decreases gap junctional intercellular communication by inducing phophorylation of connexin 43 in human ovarian carcinoma cells. J Biol Chem 278 (2003) 41294-41301
11. Carystinos G.D., Alaoui-Jamali M.A., Phipps J., Yen L., and Batist G. Upregulation of gap junctional intercellular communication and connexin43 expression by cyclic-AMP and all-trans-retinoic acid is associated with glutathione depletion and chemosensitivity in neuroblastoma cells. Cancer Chemother Pharmacol 47 (2001) 126-132
12. Umhauer S., Ruch R.J., and Fanning J. Gap junctional intercellular communication and connexin 43 expression in ovarian carcinoma. Am J Obstet Gynecol 182 (2000) 999-1000